Scott Gottlieb to biopharma: You wanted us to help modernize R&D, now go out and do it
FDA commissioner Scott Gottlieb is using the final days of his brief term to scold the drug R&D world for failing to keep up. Widely praised for his work aimed at modernizing the research tech and strategies used to advance new drugs, Gottlieb says that drug developers aren’t taking advantage of the new, more efficient approaches to clinical work — and that needs to change.
It’s not just the drug makers, says Gottlieb. CROs, who do much of the heavy lifting in the clinic, share a considerable portion of the blame.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
